Tufton Capital Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.11M | Hold |
10,326
| – | – | 0.21% | 72 |
|
|
2025
Q1 | $1.04M | Sell |
10,326
-427
| -4% | -$43.1K | 0.2% | 74 |
|
|
2024
Q4 | $960K | Hold |
10,753
| – | – | 0.18% | 76 |
|
|
2024
Q3 | $901K | Sell |
10,753
-589
| -5% | -$49.4K | 0.17% | 76 |
|
|
2024
Q2 | $873K | Buy |
11,342
+77
| +0.7% | +$5.93K | 0.17% | 79 |
|
|
2024
Q1 | $772K | Hold |
11,265
| – | – | 0.15% | 80 |
|
|
2023
Q4 | $651K | Sell |
11,265
-10
| -0.1% | -$578 | 0.14% | 82 |
|
|
2023
Q3 | $595K | Buy |
11,275
+185
| +2% | +$9.77K | 0.13% | 81 |
|
|
2023
Q2 | $600K | Sell |
11,090
-4,000
| -27% | -$216K | 0.13% | 83 |
|
|
2023
Q1 | $755K | Sell |
15,090
-50
| -0.3% | -$2.5K | 0.16% | 76 |
|
|
2022
Q4 | $701K | Hold |
15,140
| – | – | 0.15% | 75 |
|
|
2022
Q3 | $586K | Buy |
15,140
+120
| +0.8% | +$4.65K | 0.14% | 84 |
|
|
2022
Q2 | $559K | Buy |
15,020
+325
| +2% | +$12.1K | 0.1% | 85 |
|
|
2022
Q1 | $650K | Buy |
14,695
+275
| +2% | +$12.2K | 0.11% | 83 |
|
|
2021
Q4 | $612K | Buy |
14,420
+375
| +3% | +$15.9K | 0.09% | 88 |
|
|
2021
Q3 | $609K | Buy |
14,045
+150
| +1% | +$6.5K | 0.1% | 87 |
|
|
2021
Q2 | $594K | Buy |
13,895
+4,325
| +45% | +$185K | 0.1% | 88 |
|
|
2021
Q1 | $369K | Buy |
+9,570
| New | +$369K | 0.06% | 104 |
|